
Leading Oncology By Cancer Diagnostics & Treatment Markets Databank
Description
Leading Oncology By Cancer Diagnostics & Treatment Markets Databank
The Oncology market was valued at $275,700.0 Million in 2020, and is projected to reach $400,345.5 Million by 2029 growing at a CAGR of 4.28% from 2021 to 2029. Cancer treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated to reach $201,161.7 Million by 2029 with the highest CAGR of 4.43%.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
The Oncology market was valued at $275,700.0 Million in 2020, and is projected to reach $400,345.5 Million by 2029 growing at a CAGR of 4.28% from 2021 to 2029. Cancer treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated to reach $201,161.7 Million by 2029 with the highest CAGR of 4.43%.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
Table of Contents
80 Pages
- 1. GLOBAL ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
- 1.1. OVERVIEW
- 1.2. CANCER DIAGNOSTICS
- 1.2.1 CANCER DIAGNOSTICS MARKET, BY REGION
- 1.2.1.1 North America Cancer diagnostics Market, By Country
- 1.2.1.2 Europe Cancer diagnostics Market, By Country
- 1.2.1.3 Asia-Pacific Cancer diagnostics Market, By Country
- 1.2.1.4 Rest of World Cancer diagnostics Market, By Country
- 1.3. CANCER TREATMENT
- 1.3.1 CANCER TREATMENT MARKET, BY REGION
- 1.3.1.1 North America Cancer treatment Market, By Country
- 1.3.1.2 Europe Cancer treatment Market, By Country
- 1.3.1.3 Asia-Pacific Cancer treatment Market, By Country
- 1.3.1.4 Rest of World Cancer treatment Market, By Country
- TABLE 1. GLOBAL ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 2. CANCER DIAGNOSTICS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 3. NORTH AMERICA CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 4. EUROPE CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 5. ASIA-PACIFIC CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 6. REST OF WORLD CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 7. CANCER TREATMENT MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 8. NORTH AMERICA CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 9. EUROPE CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 10. ASIA-PACIFIC CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 11. REST OF WORLD CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 1. GLOBAL ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 2. CANCER DIAGNOSTICS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 3. NORTH AMERICA CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 4. EUROPE CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 5. ASIA-PACIFIC CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 6. REST OF WORLD CANCER DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 7. CANCER TREATMENT MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 8. NORTH AMERICA CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 9. EUROPE CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 10. ASIA-PACIFIC CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 11. REST OF WORLD CANCER TREATMENT MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.